NIH-funded research R01 grant

Investigating how serotonin affects breathing during fentanyl use

Official title: Serotonin mechanisms in fentanyl-induced respiratory depression

Funded at University of Michigan at Ann Arbor · NIH-11106000 · Data updated 2026-11-12

This study is looking at how fentanyl affects breathing by interfering with serotonin, and it hopes to find new ways to help people breathe better without using traditional opioid treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJune 15, 2024
Project endApril 30, 2027
Funding year2025
Award (this year)$459,424
NIH project number5R01DA061320-02
Project IDNIH-11106000 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who are prescribed fentanyl or other potent opioids and are at risk for respiratory depression.

Less likely to help

Patients who do not use opioids or have no history of respiratory issues related to opioid use may not benefit from this research.

What this research studies

This research explores the role of serotonin in respiratory depression caused by fentanyl, a powerful synthetic opioid. It aims to understand how fentanyl disrupts serotonin's ability to support normal breathing and whether activating specific serotonin receptors can counteract this effect. By studying the interactions between fentanyl and serotonin pathways in the brain, the research seeks to identify new treatment strategies that do not rely on traditional opioid receptor antagonists. Patients may benefit from insights that could lead to safer interventions for opioid-induced respiratory issues.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively prevent or reverse respiratory depression in patients using fentanyl.

How similar studies have gone: Previous research has shown promise in using serotonin pathways to address respiratory issues, suggesting that this approach may yield beneficial results.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Levitt, Erica Sawyer — University of Michigan at Ann Arbor
  • Study coordinator: Levitt, Erica Sawyer

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.